Eventide Asset Management is a Boston-based investment firm focusing on value-driven, impactful investing. They offer a range of mutual funds targeting sectors such as healthcare, life sciences, and exponential technologies. Their investment approach emphasizes both financial returns and positive societal impact, aligning with their philosophy of "investing that makes the world rejoice." Eventide's portfolio includes notable companies like Freenome, Roivant Sciences, and Pliant Therapeutics.
The firm primarily invests in Series B and C rounds, with a strong presence in the healthcare and biotechnology sectors. Eventide's unique value proposition lies in its commitment to ethical investing, combining financial expertise with a focus on companies that contribute positively to society and the environment.
Eventide - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Total Investments25
Current Portfolio Count18
Total Portfolio Exits1
Top Investment Stages
Series B10 (45.5%)
Series C6 (27.3%)
Post Ipo Equity2 (9.1%)
Series A2 (9.1%)
Series D2 (9.1%)
Stage Mix
Series B 45%Series C 27%Post Ipo Equity 9%Series A 9%Series D 9%
Concentration shown as share of disclosed investments by stage.
Eventide - Classification
- Also Known As
- Eventide Asset Management, LLC
- NAICS
- 520000Finance and Insurance
- 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
- 523900Other Financial Investment Activities
- 523990All Other Financial Investment Activities
- 523999Miscellaneous Financial Investment Activities
- SIC
- 6700Holding And Other Investment Offices
- 6720Investment Offices
- 6722Management Investment Offices, Open-end
Show 2 more industry codes
- NAICS
- 525000Funds, Trusts, and Other Financial Vehicles
- SIC
- 6000Depository Institutions